Evaluation of the Efficacy and Safety of DW1903 in Patients with Gastritis: A Randomized, Double-Blind, Noninferiority, Multicenter, Phase 3 study

Background/Aims: H2 receptor antagonists (H2RA) have been used to treat gastritis by inhibiting gastric acid. Proton pump inhibitors (PPIs) are more potent acid suppressants than H2RA. However, the efficacy and safety of low-dose PPI for treating gastritis remain unclear. The aim was to investigate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gut and liver 2024-01, Vol.18 (1), p.70
Hauptverfasser:	Jie-hyun Kim, Hwoon-yong Jung, In Kyung Yoo, Seon-young Park, Jae Gyu Kim, Jae Kyu Sung, Jin Seok Jang, Gab Jin Cheon, Kyoung Oh Kim, Tae Oh Kim, Soo Teik Lee, Kwang Bum Cho, Hoon Jai Chun, Jong-jae Park, Moo In Park, Jae-young Jang, Seong Woo Jeon, Jin Woong Cho, Dae Hwan Kang, Gwang Ha Kim, Jae J. Kim, Sang Gyun Kim, Nayoung Kim, Yong Chan Lee, Su Jin Hong, Hyun-soo Kim, Sora Lee, Sang Woo Lee
Format:	Artikel
Sprache:	kor
Schlagworte:	Gastritis Histamine H2 antagonists Phase III clinical trial Proton pump inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!